By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, tells P.B. Jayakumar about the key lessons she has learnt in business life.
Finance Minister Arun Jaitley has presented a Budget that boasts of several firsts. It is the first time that the railway and general budgets have been merged and planned and non-planned expenditure classification done away with. I believe the Finance Minister has laid out a very safe budget this year operating with fiscal prudence and … Continue reading Budget Expands Ambit of Clean India
As the debate on the pains and gains of India’s move to demonetize high-value currency notes continues to rage, I firmly believe that the digital payments economy is an idea whose time has come. History shows us how money as a ‘medium of exchange’ has evolved over several millennia from cowry shells to gold and … Continue reading Transforming India into a digital society that is less cash dependent
Over the past month, I have been a silent spectator, witnessing a miserable drama unfold in Bangalore. This is regarding a remarkable project to safeguard an important art collection through the upkeep and modernisation of an ailing state gallery the Venkatappa Art Gallery (VAG), by turning it into a new museum for the city. These plans … Continue reading What Price Philanthropy?
Today’s Indian woman is making a mark across diverse fields – from business and politics to sports and social work – breaking stereotypes and smashing glass ceilings along the way. It is interesting to note that 6 of the Top 10 Banks in India are headed by women and 12% of India’s 5,100 pilots are … Continue reading Breaking the Stereotype
Budget 2016 can be described as a ‘people’s budget’ that is aimed at spurring inclusive economic growth through measures that will drive rural development, relieve agricultural stress and boost farmers’ welfare. The Budget however has missed out on outlining innovative policies to spur India’s manufacturing sector to drive growth at a time when the economic … Continue reading A ‘People’s Budget’ to Spur Inclusive Economic Growth
Finance Minister Arun Jaitley has a challenging task at hand to present a Budget for FY17 that spurs India’s growth at a time when the economic scenario appears challenging, both externally and internally. The global economy is expected to slow down further in 2016 pulled down by weakness in major emerging economies like China, Brazil … Continue reading Pharma & Biotech Sector Must Get Its Due This Budget
The recent disruptive Parliament standoff between the Congress-led Opposition and the ruling NDA is undemocratic and unconstitutional. Preventing the Parliament from functioning is a profound governance issue. India’s progress depends on laws passed at the supreme legislative assembly viz. the Parliament. The moves by a group of parliamentarians to block the right to debate and … Continue reading Is This the India We Can Be Proud Of?
PM Narendra Modi is completing a year in power, and in the last 365 days he has been able to achieve a fair amount. His global ‘Make in India’ campaign has set the tone for transforming India into a global manufacturing hub; his ‘Jan Dhan Yojana’ has taken financial inclusion to the heart of rural … Continue reading Challenges Aside, an Eventful First Year